EWA
AUPH icon

EverSource Wealth Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

EverSource Wealth Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.3K Sell
1,080
-556
-34% -$8.88K ﹤0.01% 2502
2026
Q1 		$24.2K Buy
1,636
+608
+59% +$8.89K ﹤0.01% 2382
2025
Q4 		$16.4K Buy
1,028
+301
+41% +$4.27K ﹤0.01% 2513
2025
Q3 		$8.03K Buy
727
+319
+78% +$3.48K ﹤0.01% 2938
2025
Q2 		$3.46K Sell
408
-251
-38% -$2.01K ﹤0.01% 3306
2025
Q1 		$5.3K Buy
659
+295
+81% +$2.39K ﹤0.01% 2465
2024
Q4 		$3.27K Buy
364
+82
+29% +$669 ﹤0.01% 2527
2024
Q3 		$2.07K Buy
282
+156
+124% +$967 ﹤0.01% 2539
2024
Q2 		$741 Buy
126
+27
+27% +$142 ﹤0.01% 2797
2024
Q1 		$504 Buy
+99
New +$672 ﹤0.01% 2718

Other funds holding AUPH

LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NFG
Norris Financial Group Greenville, South Carolina $251M AUM 48.4% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

EverSource Wealth Advisors's AUPH Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Aurinia Pharmaceuticals (AUPH) stake by 34% in Q2 2026, selling an estimated $8.88K and leaving 1,080 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2502.

EverSource Wealth Advisors first reported a position in AUPH in Q1 2024 and has held it in 10 quarters since. The position peaked at $24.2K in Q1 2026. 96 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • EverSource Wealth Advisors held 1,080 shares of Aurinia Pharmaceuticals worth $18.3K as of Q2 2026.
  • EverSource Wealth Advisors sold 556 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $8.88K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2502 holding.
  • EverSource Wealth Advisors first reported a position in Aurinia Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • EverSource Wealth Advisors's Aurinia Pharmaceuticals position peaked at $24.2K in Q1 2026.
  • 96 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.